JPS6363547B2 - - Google Patents

Info

Publication number
JPS6363547B2
JPS6363547B2 JP52022115A JP2211577A JPS6363547B2 JP S6363547 B2 JPS6363547 B2 JP S6363547B2 JP 52022115 A JP52022115 A JP 52022115A JP 2211577 A JP2211577 A JP 2211577A JP S6363547 B2 JPS6363547 B2 JP S6363547B2
Authority
JP
Japan
Prior art keywords
formula
group
acid
azaguanine
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52022115A
Other languages
English (en)
Japanese (ja)
Other versions
JPS52111593A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS52111593A publication Critical patent/JPS52111593A/ja
Publication of JPS6363547B2 publication Critical patent/JPS6363547B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2211577A 1976-03-01 1977-03-01 99substitutedd88azapurine and process for preparing same Granted JPS52111593A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/662,901 US4027025A (en) 1976-03-01 1976-03-01 8-Azapurine derivatives

Publications (2)

Publication Number Publication Date
JPS52111593A JPS52111593A (en) 1977-09-19
JPS6363547B2 true JPS6363547B2 (en]) 1988-12-07

Family

ID=24659691

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2211577A Granted JPS52111593A (en) 1976-03-01 1977-03-01 99substitutedd88azapurine and process for preparing same

Country Status (10)

Country Link
US (1) US4027025A (en])
JP (1) JPS52111593A (en])
BE (1) BE851973A (en])
CH (1) CH634844A5 (en])
DE (1) DE2708826A1 (en])
DK (1) DK147623C (en])
FR (1) FR2342973A1 (en])
GB (1) GB1566493A (en])
NL (1) NL7702180A (en])
SE (1) SE431336B (en])

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4157443A (en) * 1976-11-11 1979-06-05 Ciba-Geigy Corporation V-Triazolyl-[4,5-d]-pyrimidines
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
IL78643A0 (en) * 1985-05-02 1986-08-31 Wellcome Found Purine derivatives,their preparation and pharmaceutical compositions containing them
IT1199320B (it) * 1986-12-16 1988-12-30 Malesci Sas 8-azaxantine alchilaminoalchil o eterociclilalchil sostituite sul nucleo triazolico,loro sali fisiologicamente accettabili,loro composizioni farmaceutiche ad attivita'antibroncospastica e relativo procedimento di preparazione
US4829055A (en) * 1987-01-23 1989-05-09 Naficy Sadeque S Method of treatment for herpes infections of external tissues
US4782062A (en) * 1987-05-11 1988-11-01 Merck & Co., Inc. 9-(2-hydroxymethyl)cycloalkylmethyl) guanines
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
EP0589335B1 (de) * 1992-09-24 2003-06-18 Hoechst Aktiengesellschaft N1-Substituierte 1H-1,2,3-Triazolo[4,5-d]pyrimidine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als antivirale Mittel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407204A (en) * 1944-07-22 1946-09-03 American Cyanamid Co Triazolo (d) pyrimidines and methods of preparing the same
US3819631A (en) * 1970-12-15 1974-06-25 May & Baker Ltd Azapurinones
US3836656A (en) * 1972-02-07 1974-09-17 Sandoz Ag Substituted purines as hypolipidemics

Also Published As

Publication number Publication date
US4027025A (en) 1977-05-31
NL7702180A (nl) 1977-09-05
JPS52111593A (en) 1977-09-19
DK147623B (da) 1984-10-22
DK147623C (da) 1985-07-15
BE851973A (fr) 1977-09-01
SE431336B (sv) 1984-01-30
DE2708826A1 (de) 1977-09-08
FR2342973A1 (fr) 1977-09-30
GB1566493A (en) 1980-04-30
SE7702232L (sv) 1977-09-02
DK88777A (da) 1977-09-02
FR2342973B1 (en]) 1979-03-09
CH634844A5 (de) 1983-02-28

Similar Documents

Publication Publication Date Title
JP2543822B2 (ja) グアニン誘導体
JP2788084B2 (ja) 抗ウイルス化合物
US4355032A (en) 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
JPS6147839B2 (en])
JP3090305B2 (ja) ２−（２−アミノ−１，６−ジヒドロ−６−オキソ−プリン−９−イル）メトキシ−１，３−プロパンジオール誘導体
JP2002525374A (ja) 抗ウイルスプリン誘導体
CN114763324A (zh) 一种脂质化合物及脂质体与药物组合物
EA007953B1 (ru) Способы получения 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрила
EP0369744B1 (en) Xanthine derivatives, process for their preparation and pharmaceutical compositions
CA2062299C (en) Cyclopropane derivatives
JP2738946B2 (ja) ジデオキシジデヒドロ炭素環式ヌクレオシド
JPS6363547B2 (en])
JP2001515900A (ja) 抗ウイルス薬
Semb et al. Pteroic Acid Derivatives. V. Pteroyl-α-glutamyl-α-glutamylglutamic Acid, Pteroyl-γ-glutamyl-α-glutamylglutamic Acid, Pteroyl-α-glutamyl-γ-glutamylglutamic Acid
US4636509A (en) Substituted pyrimidin-2-ones, the salts thereof, processes for their preparation, pharmaceutical compositions containing them and a method therefor
CA1075237A (en) Purine derivatives
FI57589C (fi) Foerfarande foer framstaellning av blodtrycket saenkande 6-substituerade 3-karbetoksihydrazinopyridaziner
KR980008230A (ko) 쇼크 상태의 치료 및 예방을 위한 테오필린 유도체의 용도, 크산틴 화합물 및 이의 제조방법
US4002753A (en) 6-Substituted 3-carbethoxyhydrazinopyridazines
CA1086316A (en) Purine acyclic nucleosides
JP3072600B2 (ja) 新規化合物、その製法及びそれを含む医薬組成物
WO1980000444A1 (en) Hydroxamic acid derivatives
US4189499A (en) Lysine 4-allyloxy-3-chlorophenylacetate and method of its preparation
JP4192250B2 (ja) 呼吸器疾患治療・予防用医薬
JP3145364B2 (ja) 新規化合物及び該化合物を含有する医薬組成物